Reduced expression of innate immunity-related genes in lymph node metastases of luminal breast cancer patients

Abstract Immune system plays a dual role in cancer by either targeting or supporting neoplastic cells at various stages of disease, including metastasis. Yet, the exact immune-related transcriptome profiles of primary tumours (PT) and lymph node metastases (LNM) and their evolution during luminal br...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marta Popeda, Aleksandra Markiewicz, Tomasz Stokowy, Jolanta Szade, Magdalena Niemira, Adam Kretowski, Natalia Bednarz-Knoll, Anna J. Zaczek
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9e4c0bd97927494ba1f6cc217ca25478
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9e4c0bd97927494ba1f6cc217ca25478
record_format dspace
spelling oai:doaj.org-article:9e4c0bd97927494ba1f6cc217ca254782021-12-02T13:33:44ZReduced expression of innate immunity-related genes in lymph node metastases of luminal breast cancer patients10.1038/s41598-021-84568-02045-2322https://doaj.org/article/9e4c0bd97927494ba1f6cc217ca254782021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-84568-0https://doaj.org/toc/2045-2322Abstract Immune system plays a dual role in cancer by either targeting or supporting neoplastic cells at various stages of disease, including metastasis. Yet, the exact immune-related transcriptome profiles of primary tumours (PT) and lymph node metastases (LNM) and their evolution during luminal breast cancer (BCa) dissemination remain undiscovered. In order to identify the immune-related transcriptome changes that accompany lymphatic spread, we analysed PT-LNM pairs of luminal BCa using NanoString technology. Decrease in complement C3—one of the top-downregulated genes, in LNM was validated at the protein level using immunohistochemistry. Thirty-three of 360 analysed genes were downregulated (9%), whereas only 3 (0.8%) upregulated in LNM when compared to the corresponding PT. In LNM, reduced expression was observed in genes related to innate immunity, particularly to the complement system (C1QB, C1S, C1R, C4B, CFB, C3, SERPING1 and C3AR1). In validation cohort, complement C3 protein was less frequently expressed in LNM than in PT and it was associated with worse prognosis. To conclude, local expression of the complement system components declines during lymphatic spread of non-metastatic luminal BCa, whilst further reduction of tumoral complement C3 in LNM is indicative for poor survival. This points to context-dependent role of complement C3 in BCa dissemination.Marta PopedaAleksandra MarkiewiczTomasz StokowyJolanta SzadeMagdalena NiemiraAdam KretowskiNatalia Bednarz-KnollAnna J. ZaczekNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Marta Popeda
Aleksandra Markiewicz
Tomasz Stokowy
Jolanta Szade
Magdalena Niemira
Adam Kretowski
Natalia Bednarz-Knoll
Anna J. Zaczek
Reduced expression of innate immunity-related genes in lymph node metastases of luminal breast cancer patients
description Abstract Immune system plays a dual role in cancer by either targeting or supporting neoplastic cells at various stages of disease, including metastasis. Yet, the exact immune-related transcriptome profiles of primary tumours (PT) and lymph node metastases (LNM) and their evolution during luminal breast cancer (BCa) dissemination remain undiscovered. In order to identify the immune-related transcriptome changes that accompany lymphatic spread, we analysed PT-LNM pairs of luminal BCa using NanoString technology. Decrease in complement C3—one of the top-downregulated genes, in LNM was validated at the protein level using immunohistochemistry. Thirty-three of 360 analysed genes were downregulated (9%), whereas only 3 (0.8%) upregulated in LNM when compared to the corresponding PT. In LNM, reduced expression was observed in genes related to innate immunity, particularly to the complement system (C1QB, C1S, C1R, C4B, CFB, C3, SERPING1 and C3AR1). In validation cohort, complement C3 protein was less frequently expressed in LNM than in PT and it was associated with worse prognosis. To conclude, local expression of the complement system components declines during lymphatic spread of non-metastatic luminal BCa, whilst further reduction of tumoral complement C3 in LNM is indicative for poor survival. This points to context-dependent role of complement C3 in BCa dissemination.
format article
author Marta Popeda
Aleksandra Markiewicz
Tomasz Stokowy
Jolanta Szade
Magdalena Niemira
Adam Kretowski
Natalia Bednarz-Knoll
Anna J. Zaczek
author_facet Marta Popeda
Aleksandra Markiewicz
Tomasz Stokowy
Jolanta Szade
Magdalena Niemira
Adam Kretowski
Natalia Bednarz-Knoll
Anna J. Zaczek
author_sort Marta Popeda
title Reduced expression of innate immunity-related genes in lymph node metastases of luminal breast cancer patients
title_short Reduced expression of innate immunity-related genes in lymph node metastases of luminal breast cancer patients
title_full Reduced expression of innate immunity-related genes in lymph node metastases of luminal breast cancer patients
title_fullStr Reduced expression of innate immunity-related genes in lymph node metastases of luminal breast cancer patients
title_full_unstemmed Reduced expression of innate immunity-related genes in lymph node metastases of luminal breast cancer patients
title_sort reduced expression of innate immunity-related genes in lymph node metastases of luminal breast cancer patients
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/9e4c0bd97927494ba1f6cc217ca25478
work_keys_str_mv AT martapopeda reducedexpressionofinnateimmunityrelatedgenesinlymphnodemetastasesofluminalbreastcancerpatients
AT aleksandramarkiewicz reducedexpressionofinnateimmunityrelatedgenesinlymphnodemetastasesofluminalbreastcancerpatients
AT tomaszstokowy reducedexpressionofinnateimmunityrelatedgenesinlymphnodemetastasesofluminalbreastcancerpatients
AT jolantaszade reducedexpressionofinnateimmunityrelatedgenesinlymphnodemetastasesofluminalbreastcancerpatients
AT magdalenaniemira reducedexpressionofinnateimmunityrelatedgenesinlymphnodemetastasesofluminalbreastcancerpatients
AT adamkretowski reducedexpressionofinnateimmunityrelatedgenesinlymphnodemetastasesofluminalbreastcancerpatients
AT nataliabednarzknoll reducedexpressionofinnateimmunityrelatedgenesinlymphnodemetastasesofluminalbreastcancerpatients
AT annajzaczek reducedexpressionofinnateimmunityrelatedgenesinlymphnodemetastasesofluminalbreastcancerpatients
_version_ 1718392870342230016